关注
David S. Nakhla
David S. Nakhla
Formulation Scientist | Shin-Etsu - SE Tylose USA, Inc.
在 uiowa.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Precise simultaneous quantification of methadone and cocaine in rat serum and brain tissue samples following their successive ip administration
DS Nakhla, LA Hussein, N Magdy, IA Abdallah, HE Hassan
Journal of Chromatography B 1048, 19-29, 2017
92017
Comparative study of different spectrophotometric methods for simultaneous determination of tramadol and paracetamol in pharmaceutical formulations
DS Nakhla, LA Hussein, N Magdy, IA Abdallah
Journal of Applied Spectroscopy 88, 894-900, 2021
32021
Selective androgen receptor modulator microparticle formulation reverses muscle hyperalgesia in a mouse model of widespread muscle pain
JB Lesnak, DS Nakhla, AN Plumb, A McMillan, S Saha, N Gupta, Y Xu, ...
Pain 164 (7), 1512-1523, 2023
22023
Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo …
DS Nakhla, AI Mekkawy, YW Naguib, AD Silva, D Gao, JA Kim, ...
International Journal of Pharmaceutics, 123693, 2023
12023
Select Androgen Receptor Modulator Microparticle Formulation Reverses Muscle Hyperalgesia in Mouse Model of Widespread Muscle Pain
J Lesnak, D Nakhla, A Salem, KA Sluka
The journal of pain 23 (5), 20, 2022
12022
Sensitive UPLC–MS/MS Method for Oxycodone Quantification in Serum and Brain Tissue Homogenates: Application to an Interaction Study in Rats
D Nakhla, L Hussien, N Nasef, H Hassan, I Abdallah
Journal of Advanced Pharmacy Research 4 (3), 83-93, 2020
12020
Compositions comprising molecules for cystic fibrosis treatment
AK Salem, DA Stoltz, MJ Welsh, S Ernst, YW Naguib, DS NAkhla, ...
US Patent App. 18/256,593, 2024
2024
Sustained release formulations comprising a selective androgen receptor modulator
KA Sluka, J Lesnak, AK Salem, D Nakhla
US Patent WO2022271951A1, 2022
2022
Drug eluting 3D-printed scaffolds for bone tissue engineering
J Chakka, D Nakhla, S Saha, S Elangovan, A Salem
TISSUE ENGINEERING PART A 28, S487-S487, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–9